Farokhzad O.C.
105
Coauthors
15
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2007 | 4 |
| 2008 | 5 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 15 |
| Nanopartícula | 5 |
| Farmacología | 4 |
| Inmunología | 2 |
| Ciencia de materiales | 2 |
| Bioquímica | 1 |
| Biotecnología | 1 |
| Biomedicina | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 13 |
| Enfermedades | 5 |
| Ingeniería y operaciones afines | 4 |
| Fisiología y materias afines | 2 |
| Química analítica | 2 |
| Medicina y salud | 2 |
| Microorganismos, hongos y algas | 1 |
| Física aplicada | 1 |
| Salud y seguridad personal | 1 |
| Ingeniería civil | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 15 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Frank Alexis | 15 |
| Langer R.S. | 11 |
| Radovic-Moreno A.F. | 6 |
| Pridgen E.M. | 6 |
| Basto P.A. | 5 |
| Zhang L. | 5 |
| Gu F.X. | 5 |
| Levy-Nissenbaum E. | 5 |
| Wang A.Z. | 4 |
| Shi J. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Polymeric nanoparticle drug delivery technologies for oral delivery applications
ReviewAbstract: Introduction: Many therapeutics are limited to parenteral administration. Oral administration is a dPalabras claves:chemotherapy, Inflammatory bowel disease, Insulin, M cells, mucoadhesives, mucosal vaccinations, oral delivery, Polymeric nanoparticles, transcytosisAutores:Farokhzad O.C., Frank Alexis, Pridgen E.M.Fuentes:scopusBiodistribution and Pharmacokinetics of Nanoprobes
Book PartAbstract:Palabras claves:Nanoparticle-based technology - factors affecting nanoprobe biodistribution and pharmacokinetics, as size, shape, surface functionality/coating and charge, Nanoprobe biodistribution and pharmacokinetics - nanoprobe toxicity, in biomedical and clinical applications, Theragnostic nanoprobes, and nanoparticle delivery systems - therapeutic vehicle with multiple examples approved by FDA for therapyAutores:Farokhzad O.C., Frank Alexis, Kolishetti N., Pridgen E.M.Fuentes:scopusFactors affecting the clearance and biodistribution of polymeric nanoparticles
Conference ObjectAbstract: Nanoparticle (NP) drug delivery systems (5-250 nm) have the potential to improve current disease thePalabras claves:biodistribution, Circulation half-life, Polymeric nanoparticlesAutores:Farokhzad O.C., Frank Alexis, Molnar L.K., Pridgen E.M.Fuentes:scopusNanoparticle technologies for cancer therapy
ReviewAbstract: Nanoparticles as drug delivery systems enable unique approaches for cancer treatment. Over the lastPalabras claves:cancer therapy, drug delivery, Metastatic cancer, Nanoparticle, TargetedAutores:Farokhzad O.C., Frank Alexis, Langer R.S., Pridgen E.M.Fuentes:scopusTargeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopus